{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:59:37Z","timestamp":1790395177094,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journalofclinicalvirology.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.jcv.2015.09.011","type":"journal-article","created":{"date-parts":[[2015,10,18]],"date-time":"2015-10-18T10:29:44Z","timestamp":1445164184000},"page":"8-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Role of TLR gene expression and cytokine profiling in the immunopathogenesis of viral hepatitis E"],"prefix":"10.1016","volume":"73","author":[{"given":"Manasi","family":"Majumdar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.K.","family":"Ratho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogesh","family":"Chawla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mini P.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2015.09.011_bib0005","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/0042-6822(91)90760-9","article-title":"Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome","volume":"185","author":"Tam","year":"1991","journal-title":"Virology"},{"key":"10.1016\/j.jcv.2015.09.011_bib0010","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0166-0934(92)90180-L","article-title":"Solid-phase enzyme-linked immunosorbent assay for hepatitis E virus IgG and IgM antibodies utilizing recombinant antigens and synthetic peptides","volume":"38","author":"Dawson","year":"1992","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jcv.2015.09.011_bib0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.virusres.2011.02.007","article-title":"Discovery of hepatitis E: the epidemic non-A, non-B hepatitis 30 years down the memory lane","volume":"161","author":"Khuroo","year":"2011","journal-title":"Virus Res."},{"key":"10.1016\/j.jcv.2015.09.011_bib0020","unstructured":"WHO 2014; \u201dFact sheet N\u00b0280\u201d. Available at: http:\/\/www.who.int\/mediacentre\/factsheets\/fs280\/en\/ (accessed 21.05.15.)."},{"key":"10.1016\/j.jcv.2015.09.011_bib0025","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/0002-9343(81)90758-0","article-title":"Incidence and severity of viral hepatitis in pregnancy","volume":"70","author":"Khuroo","year":"1981","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jcv.2015.09.011_bib0030","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1002\/hep.24674","article-title":"Hepatitis E","volume":"54","author":"Aggarwal","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jcv.2015.09.011_bib0035","first-page":"203","article-title":"Viral hepatitis in India","volume":"19","author":"Acharya","year":"2006","journal-title":"Natl. Med. J. India"},{"key":"10.1016\/j.jcv.2015.09.011_bib0040","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.virusres.2011.06.006","article-title":"Serological diagnostics of hepatitis E virus infection","volume":"161","author":"Khudyakov","year":"2011","journal-title":"Virus Res."},{"key":"10.1016\/j.jcv.2015.09.011_bib0045","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1089\/vim.2006.0053","article-title":"Cellular immune responses in acute hepatitis E virus infection to the viral open reading frame 2 protein","volume":"20","author":"Srivastava","year":"2007","journal-title":"Viral Immunol."},{"key":"10.1016\/j.jcv.2015.09.011_bib0050","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1440-1746.2010.06356.x","article-title":"Adaptive immune responses during acute uncomplicated and fulminant hepatitis E","volume":"26","author":"Srivastava","year":"2011","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jcv.2015.09.011_bib0055","doi-asserted-by":"crossref","first-page":"64","DOI":"10.4103\/0255-0857.108725","article-title":"Evaluation of antigenicity and cell mediated immunity of hepatitis E virus patients: using non-radioactive MTT assay","volume":"31","author":"Majumdar","year":"2013","journal-title":"Indian J. Med. Microbiol."},{"key":"10.1016\/j.jcv.2015.09.011_bib0060","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen recognition and innate immunity","volume":"124","author":"Akira","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.jcv.2015.09.011_bib0065","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.it.2013.06.003","article-title":"Toll-like receptor regulation of effector T lymphocyte function","volume":"34","author":"Reynolds","year":"2013","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jcv.2015.09.011_bib0070","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/icb.2013.102","article-title":"The use of a TLR2 agonist-based adjuvant for enhancing effector and memory CD8 T-cell responses","volume":"92","author":"Chua","year":"2014","journal-title":"Immunol. Cell. Biol."},{"key":"10.1016\/j.jcv.2015.09.011_bib0075","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.4049\/jimmunol.172.10.6065","article-title":"Toll-like receptor ligands directly promote activated CD4+T cell survival","volume":"172","author":"Gelman","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.jcv.2015.09.011_bib0080","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.addr.2007.11.003","article-title":"Toll-like receptors regulation of viral infection and disease","volume":"60","author":"Thompson","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jcv.2015.09.011_bib0085","doi-asserted-by":"crossref","first-page":"6183","DOI":"10.2741\/3146","article-title":"Virus associated innate immunity in liver","volume":"13","author":"Kanto","year":"2008","journal-title":"Front Biosci."},{"key":"10.1016\/j.jcv.2015.09.011_bib0090","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/hep.22306","article-title":"Toll-like receptors and adaptor molecules in liver disease: update","volume":"48","author":"Seki","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jcv.2015.09.011_bib0095","series-title":"Progress in Liver Diseases","first-page":"282","article-title":"The management of fulminant hepatic failure","author":"Trey","year":"1970"},{"key":"10.1016\/j.jcv.2015.09.011_bib0100","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1111\/liv.12197","article-title":"High levels of circulating HMGB1 as a biomarker of acute liver failure in patients with viral hepatitis E","volume":"33","author":"Majumdar","year":"2013","journal-title":"Liver Int."},{"key":"10.1016\/j.jcv.2015.09.011_bib0105","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.clim.2008.04.006","article-title":"Expression profiles and function of Toll-like receptors 2 and 4 in peripheral blood mononuclear cells of chronic hepatitis B patients","volume":"128","author":"Chen","year":"2008","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jcv.2015.09.011_bib0110","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4103\/0255-0857.129806","article-title":"Evaluating the role of low-speed centrifugation towards transfecting human peripheral blood mononuclear cell culture","volume":"32","author":"Majumdar","year":"2014","journal-title":"Indian J. Med. Microbiol."},{"key":"10.1016\/j.jcv.2015.09.011_bib0115","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/41131","article-title":"A human homologue of the Drosophila Toll protein signals activation of adaptive immunity","volume":"388","author":"Medzhitov","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.jcv.2015.09.011_bib0120","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2249.2006.03301.x","article-title":"Translational mini-review series on Toll-like receptors: recent advances in understanding the role of Toll-like receptors in anti-viral immunity","volume":"147","author":"Bowie","year":"2007","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jcv.2015.09.011_bib0125","doi-asserted-by":"crossref","first-page":"12273","DOI":"10.1128\/JVI.79.19.12273-12279.2005","article-title":"Toll-like receptor 3 is induced by and mediates antiviral activity against rhinovirus infection of human bronchial epithelial cells","volume":"79","author":"Hewson","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.jcv.2015.09.011_bib0130","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1128\/JVI.80.2.866-874.2006","article-title":"Hepatitis C Virus induces toll-like receptor 4 expression, leading to enhanced production of beta interferon and interleukin-6","volume":"80","author":"Machida","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.jcv.2015.09.011_bib0135","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1042\/CS20110065","article-title":"Role of Toll-like receptors in liver health and disease","volume":"121","author":"Broering","year":"2011","journal-title":"Clin. Sci. (Lond)."},{"key":"10.1016\/j.jcv.2015.09.011_bib0140","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/hep.22751","article-title":"Hepatitis B. virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells","volume":"49","author":"Wu","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jcv.2015.09.011_bib0145","doi-asserted-by":"crossref","first-page":"7269","DOI":"10.1128\/JVI.79.11.7269-7272.2005","article-title":"Toll-like receptor signaling inhibits hepatitis B virus replication in vivo","volume":"79","author":"Isogawa","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.jcv.2015.09.011_bib0150","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000214862","article-title":"Viral load, antibody titers and recombinant open reading frame 2 protein-induced TH1\/TH2 cytokines and cellular immune responses in self-limiting and fulminant hepatitis E","volume":"52","author":"Saravanabalaji","year":"2009","journal-title":"Intervirology"},{"key":"10.1016\/j.jcv.2015.09.011_bib0155","doi-asserted-by":"crossref","first-page":"680","DOI":"10.7326\/0003-4819-125-8-199610150-00009","article-title":"Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS)","volume":"125","author":"Bone","year":"1996","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jcv.2015.09.011_bib0160","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1084\/jem.20101664","article-title":"Type I interferon: friend or foe?","volume":"207","author":"Trinchieri","year":"2010","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.jcv.2015.09.011_bib0165","doi-asserted-by":"crossref","first-page":"20446","DOI":"10.1073\/pnas.0810372105","article-title":"A critical link between Toll-like receptor 3 and type II interferon signaling pathways in antiviral innate immunity","volume":"105","author":"Negishi","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jcv.2015.09.011_bib0170","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nature03326","article-title":"Toll-like receptor 3 promotes cross-priming to virus-infected cells","volume":"433","author":"Schulz","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.jcv.2015.09.011_bib0175","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/hep.20839","article-title":"Isatoribine, an agonist of TLR7, reduces plasma virus concentration in chronic hepatitis C infection","volume":"42","author":"Horsmans","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jcv.2015.09.011_bib0180","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1517\/14712598.7.11.1731","article-title":"Review of hepatitis B surface antigen-1018 ISS adjuvant-containing vaccine safety and efficacy","volume":"7","author":"Barry","year":"2007","journal-title":"Expert Opin. Biol. Ther."}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653215006800?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653215006800?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T13:57:15Z","timestamp":1537279035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653215006800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":36,"alternative-id":["S1386653215006800"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2015.09.011","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of TLR gene expression and cytokine profiling in the immunopathogenesis of viral hepatitis E","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2015.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}